Moderna's (MRNA.O) stock dropped 2% in a volatile session on Tuesday, with the COVID-19 vaccine maker the most heavily traded company on Wall Street ahead of its debut in the S&P 500 on Wednesday.
Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photostock dropped 2% in a volatile session on Tuesday, with the COVID-19 vaccine maker the most heavily traded company on Wall Street ahead of its debut in the S&P 500 on Wednesday.
Moderna joins the S&P 500 as of the start of trading on Wednesday. That means index funds managing over $5 trillion will have to have bought about 17% of the company's stock, according to Howard Silverblatt, a senior index analyst at S&P Dow Jones Indices. During Tuesday's session, Moderna surged as much as 9% and fell as much as 7%. The stock has gained about 18% since July 15, when S&P Dow Jones Indices announced its addition to the S&P 500.The latest volatility in Moderna's stock comes as concerns increase over the highly contagious Delta variant of COVID-19, now responsible for the majority of new infections. Fears about a resurgence in the virus slammed Wall Street on Monday.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Dow futures sink more than 500 points as Delta variant fears hit Wall Street hardWall Street investors are getting spooked by the rising numbers of Covid-19 cases as the Delta variant spreads across the globe.
Consulte Mais informação »
Asian markets fall on COVID-19 spread, Wall Street declinesAsian shares fell across the board Monday, as pessimism took hold following rising COVID-19 infections regionally and Wall Street's first weekly loss...
Consulte Mais informação »
Wall Street Watchdog Keeps Bitcoin ETFs on IceFor eight years, asset managers have tried to launch bitcoin exchange-traded funds, but success seems no closer now than it did in 2013
Consulte Mais informação »
Goldman Sachs: Biden's antitrust crackdown could slow the deal boom on Wall StreetPresident Joe Biden is cracking down on monopolies. And that has some on Wall Street worried.
Consulte Mais informação »
These are Wall Street’s favorite ‘defensive’ stocks as market slidesNew for subscribers: These are Wall Street’s favorite ‘defensive’ stocks as market slides. Check out CNBCPro today.
Consulte Mais informação »